Trial intelligence / Profile preview

Dexmedetomidine plus ropivacaine concentration comparison for postoperative brachial plexus analgesia after elbow surgery

ChiCTR1900021265Phase 4Recruiting

Sponsor
Ningbo Medical Center Lihuili Eastern Hospital
Start
Feb 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of dexmedetomidine and ropivacaine in postoperative pain (4 arms), sponsored by Ningbo Medical Center Lihuili Eastern Hospital. Primary endpoints: Analgesic indicators, Movement indicators and 1 more. Started Feb 2019; status: recruiting.

02

Drugs

dexmedetomidineropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR1900021265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900021265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call